MedPath

Dorpen

Brand Name: Dorpen

Generic Name: Doripenem (as monohydrate)

Active
Registration Number

DR-XY48333

Dosage Form

Powder for Injection for I.V. Infusion

Issuance Date

September 1, 2022

Expiry Date

September 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500mg
PackagingSP Type I glass vial with bromobutyl rubber plug and aluminum flip off seal (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Carbapenem)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Doripenem (as monohydrate)Active
Monograph: doripenem (as monohydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform